Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    MA01 - Molecular Subtypes and Prognostic Factors for SCLC and Neuroendocrine Tumors

    • 10:45 - 11:45
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
    • +

      MA01.05 - Immuno-microenvironment (TIME) Heterogeneity of Small Cell Lung Cancer (SCLC) Stratified by Molecular Subtypes

      10:57 - 11:02  |  Presenter: Jiyan DONG

      • Abstract

      Loading...

  • +

    MA05 - Immune Landscape and Molecular Profiling of Lung Cancer

    • 15:45 - 16:45
    • 8/07/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Tumor Biology and Biomarkers
    • +

      MA05.03 - Utilization of Genomic Mutation Signature to Predict the Immunotherapy Response in Non-small Cell Lung Cancer

      15:47 - 15:52  |  Presenter: Wenbin Li

      • Abstract

      Loading...

  • +

    EP02.01 - Early Stage Non-small Cell Lung Cancer - Biomarkers

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Early Stage Non-small Cell Lung Cancer - Biomarkers
    • +

      EP02.01-011 - Immune-related Histologic Phenotype in Pretreatment Tumor Biopsy Predicts Efficacy of Neoadjuvant Anti-PD-1 Treatment in Squamous Lung Cancer

      Presenter: Pei Yuan

      • Abstract

      Loading...

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      EP08.02-009 - Progression Pattern, Resistance Mechanism and Subsequent Therapy for ALK Positive NSCLC in the Era of Second—Generation ALK—TKIs

      Presenter: Zihua Zou

      • Abstract

      Loading...

    • +

      EP08.02-091 - Disease Monitoring of EGFR-mutated NSCLC Patients Treated with TKIs via EGFR Status in Circulating ctDNA

      Presenter: Yan Li

      • Abstract

      Loading...

  • +

    EP11.01 - Pathology - Genomics & Analytics

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Pathology - Genomics & Analytics
    • +

      EP11.01-014 - Optimizing Targetable Gene Screening by Sequential Multi-platform Detection Applied to Driver-negative mNSCLC Patients Detected by DNA-NGS

      Presenter: Yaxi Wang

      • Abstract

      Loading...